- All sections
- C - Chemistrymetallurgy
- C07J - Steroids
- C07J 13/00 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17
Patent holdings for IPC class C07J 13/00
Total number of patents in this class: 138
10-year publication summary
11
|
17
|
8
|
22
|
18
|
12
|
8
|
6
|
8
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Sage Therapeutics, Inc. | 362 |
50 |
Allergan Sales, LLC | 250 |
8 |
Washington University | 1600 |
8 |
Nzp UK Limited | 28 |
7 |
The Board of Trustees of the University of Illinois | 2686 |
3 |
Prevacus, Inc. | 7 |
3 |
LEO Pharma A/S | 432 |
3 |
Council of Scientific & Industrial Research | 1423 |
2 |
Kythera Biopharmaceuticals, Inc. | 29 |
2 |
ReveraGen Biopharma, Inc. | 31 |
2 |
Universite de Bordeaux | 854 |
2 |
Ustav Organicke Chemie a Biochemie AV CR, V.v.i. | 124 |
2 |
Fyziologicky Ustav AV CR, V.v.i. | 14 |
2 |
Coral Drugs Pvt. Ltd. | 5 |
2 |
Brii Biosciences, Inc. | 32 |
2 |
Estetra SRL | 96 |
2 |
Board of Regents, The University of Texas System | 5754 |
1 |
Ajinomoto Co., Inc. | 2299 |
1 |
Duke University | 3063 |
1 |
Purdue Research Foundation | 3571 |
1 |
Other owners | 34 |